Sign in

CIK 0001712762

  • Emerging growth company

bioAffinity Technologies, Inc.

Sign in to watch
Ticker
BIAF
Exchange
Nasdaq
Industry
Services-Commercial Physical & Biological Research
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
465211056
Phone
+1 210-698-5334
Business address
3300 NACOGDOCHES ROAD, SUITE 216, SAN ANTONIO, TX, 78217
Former names
bioAffinity Technologies, Inc.

Securities

  • BIAF Common Stock Nasdaq
  • BIAFW Warrant Nasdaq
Open-market buys, last 90 days
$1,039,671
in 1 filing
Open-market sales, last 90 days
$1,175,048
in 1 filing

Net −$135,378. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. HRT FINANCIAL LP −$135K 10% owner sold 58% of stake
Date Insider Transaction Shares Price Value Owned after
2025-01-10 Edwards James Michael VP and CFO Grant or award +6,172 120,128
2024-11-05 Edwards James Michael VP and CFO Grant or award +100,000 113,956
2022-11-17 Edwards James Michael Chief Financial Officer Grant or award +3,619 36,815
2022-09-06 Edwards James Michael Chief Financial Officer Conversion +2,243 $4.20 $9K 32,566
2022-09-06 Edwards James Michael Chief Financial Officer Conversion · Secured Convertible Promissory Note −0 0
2022-09-06 Edwards James Michael Chief Financial Officer Grant or award · Warrant (right to buy) +1,903 1,903
2022-09-01 Edwards James Michael Chief Financial Officer Purchase +2,448 30,323
2022-09-01 Edwards James Michael Chief Financial Officer Purchase · Warrants (right to buy) +2,448 2,448
2022-09-01 Edwards James Michael Chief Financial Officer Purchase · Non-tradeable Warrants (right to buy) +2,448 2,448
2022-07-20 Edwards James Michael Chief Financial Officer Grant or award · Warrant (right to buy) +761 761

Page 1 of 1 · 10 trades